Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
cardiac remodelling
heart failure
heart failure with normal ejection fraction
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
06
2019
revised:
25
09
2019
accepted:
19
02
2020
entrez:
29
4
2020
pubmed:
29
4
2020
medline:
1
7
2020
Statut:
epublish
Résumé
It has been reported that recovery of left ventricular ejection fraction (LVEF) is associated with better prognosis in heart failure (HF) patients with reduced EF (rEF). However, change of LVEF has not yet been investigated in cases of HF with preserved EF (HFpEF). Consecutive 1082 HFpEF patients, who had been admitted to hospital due to decompensated HF (EF >50% at the first LVEF assessment at discharge), were enrolled, and LVEF was reassessed within 6 months in the outpatient setting (second LVEF assessment). Among the HFpEF patients, LVEF of 758 patients remained above 50% (pEF group), 138 patients had LVEF of 40%-49% (midrange EF, mrEF group) and 186 patients had LVEF of less than 40% (rEF group). In the multivariable logistic regression analysis, younger age and presence of higher levels of troponin I were predictors of rEF (worsened HFpEF). In the Kaplan-Meier analysis, the cardiac event rate of the groups progressively increased from pEF, mrEF to rEF (log-rank, p<0.001), whereas all-cause mortality did not significantly differ among the groups. In the multivariable Cox proportional hazard analysis, rEF (vs pEF) was not a predictor of all-cause mortality, but an independent predictor of increased cardiac event rates (HR 1.424, 95% CI 1.020 to 1.861, p=0.039). An initial assessment of LVEF and LVEF changes are important for deciding treatment and predicting prognosis in HFpEF patients. In addition, several confounding factors are associated with LVEF changes in worsened HFpEF patients.
Sections du résumé
Background
It has been reported that recovery of left ventricular ejection fraction (LVEF) is associated with better prognosis in heart failure (HF) patients with reduced EF (rEF). However, change of LVEF has not yet been investigated in cases of HF with preserved EF (HFpEF).
Methods and results
Consecutive 1082 HFpEF patients, who had been admitted to hospital due to decompensated HF (EF >50% at the first LVEF assessment at discharge), were enrolled, and LVEF was reassessed within 6 months in the outpatient setting (second LVEF assessment). Among the HFpEF patients, LVEF of 758 patients remained above 50% (pEF group), 138 patients had LVEF of 40%-49% (midrange EF, mrEF group) and 186 patients had LVEF of less than 40% (rEF group). In the multivariable logistic regression analysis, younger age and presence of higher levels of troponin I were predictors of rEF (worsened HFpEF). In the Kaplan-Meier analysis, the cardiac event rate of the groups progressively increased from pEF, mrEF to rEF (log-rank, p<0.001), whereas all-cause mortality did not significantly differ among the groups. In the multivariable Cox proportional hazard analysis, rEF (vs pEF) was not a predictor of all-cause mortality, but an independent predictor of increased cardiac event rates (HR 1.424, 95% CI 1.020 to 1.861, p=0.039).
Conclusion
An initial assessment of LVEF and LVEF changes are important for deciding treatment and predicting prognosis in HFpEF patients. In addition, several confounding factors are associated with LVEF changes in worsened HFpEF patients.
Identifiants
pubmed: 32341787
doi: 10.1136/openhrt-2019-001112
pii: openhrt-2019-001112
pmc: PMC7174028
doi:
Substances chimiques
Biomarkers
0
Troponin I
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e001112Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eur J Heart Fail. 2013 May;15(5):543-50
pubmed: 23250911
Eur J Prev Cardiol. 2018 Mar;25(4):366-376
pubmed: 29313369
Heart Fail Rev. 2017 Nov;22(6):641-655
pubmed: 28601914
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Heart Vessels. 2014 Jul;29(4):470-7
pubmed: 23836070
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811159
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Circ Res. 2014 Jun 20;115(1):79-96
pubmed: 24951759
J Card Fail. 2015 Aug;21(8):621-7
pubmed: 25982827
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1123-9
pubmed: 26297226
Circ Heart Fail. 2013 Mar;6(2):279-86
pubmed: 23271790
Heart Vessels. 2015 May;30(3):318-24
pubmed: 24481540
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93
pubmed: 25456761
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343
Eur J Heart Fail. 2018 Mar;20(3):431-432
pubmed: 29333631
Circ J. 2015;79(4):785-93
pubmed: 25739573
Clin Res Cardiol. 2011 Sep;100(9):755-64
pubmed: 21416189
J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228
pubmed: 27855811
Eur J Heart Fail. 2017 Dec;19(12):1615-1623
pubmed: 28387002
Circ Heart Fail. 2016 Jun;9(6):
pubmed: 27266854
J Am Coll Cardiol. 2013 Apr 9;61(14):1498-506
pubmed: 23500300
Eur J Heart Fail. 2017 Oct;19(10):1258-1269
pubmed: 28370829
Eur Heart J. 2011 Nov;32(22):2851-906
pubmed: 21873417
JAMA Cardiol. 2016 Aug 1;1(5):510-8
pubmed: 27434402
Clin Cardiol. 2015 Jul;38(7):413-21
pubmed: 25966016
Circ Heart Fail. 2012 Nov;5(6):720-6
pubmed: 22936826
Circ Heart Fail. 2016 Oct;9(10):
pubmed: 27656000
Can J Cardiol. 2018 Jan;34(1):80-87
pubmed: 29275887
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
J Atheroscler Thromb. 2019 Apr 1;26(4):315-327
pubmed: 30814385
Eur Heart J. 2014 Oct 21;35(40):2797-815
pubmed: 25104786
J Am Coll Cardiol. 2018 Aug 7;72(6):591-601
pubmed: 30071987
Circulation. 2014 Jun 10;129(23):2380-7
pubmed: 24799515
J Cardiol. 2014 Oct;64(4):256-64
pubmed: 24674751
N Engl J Med. 2016 Nov 10;375(19):1868-1877
pubmed: 27959663
Circ Heart Fail. 2016 Jul;9(7):
pubmed: 27413037